glp 1 drugs in india Did you know? is now the world's 2nd largest GLP‑1 market. With 2026 patent expiries ahead, a massive opportunity could open up diabetes & obesity care #MarketTalks #EdelweissMutualFund India's weight-loss drug rush kicks

Prioritizing 7 to 9 hours of quality sleep supports cardiovascular adaptation

doi: 10.1007/S12630-023-02440-3 109 FezzaRRainsBFezzaTFezzaJP

Adequate protein and micronutrient intake can significantly reduce the risk

Yukardaki FT infografii, GLP-1 hormonunun al nasl bastrdn ve kilo kaybna nasl yol atn basite zetliyor

These markers of plaque instability and inflammation include those linked to plaque hemorrhage, matrix turnover, cholesterol metabolism, and leukocyte recruitment

Plan costs increase to unsustainable levels, threatening a plans solvency Pain Point : GLP-1 medications, while effective for diabetes and weight loss, drive up health care costs for employers and their self-funded plans